2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $1B | $1.4B | $1.7B | $2.1B | $2.5B |
Cost of Revenue | $658M | $992M | $1.1B | $1.3B | $1.6B |
Gross Profit | $360M | $441M | $596M | $757M | $925M |
Gross Profit % | 35% | 31% | 35% | 36% | 37% |
R&D Expenses | $0.078 | $0.043 | $0.1 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $71M | $57M | $163M | $61M | $230M |
Dep. & Amort. | $68M | $113M | $109M | $116M | $168M |
Def. Tax | $203K | -$1.2M | $15M | $37M | $17M |
Stock Comp. | $11M | $86M | $77M | $70M | $31M |
Chg. in WC | -$40M | -$29M | -$75M | $38M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $313M | $387M | $993M | $839M | $540M |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $313M | $387M | $993M | $839M | $540M |
Receivables | $178M | $211M | $231M | $331M | $390M |
Inventory | $494M | -$2.4B | -$2.6B | -$36M | $0 |
Ryan Specialty achieved 12.8% organic revenue growth in 2024, marking its 14th consecutive year of double-digit organic growth, with total revenue surpassing $2.5 billion, up 21% year-over-year.
The company completed a record year of M&A, acquiring seven firms with trailing revenue of over $265 million, including Velocity Risk Underwriters, which added $81 million in annual revenue and expanded property capabilities.
For 2025, Ryan Specialty is guiding organic revenue growth between 11-13% and adjusted EBITDA margin between 32.5-33.5%, with a long-term target of 35% adjusted EBITDA margin by 2027.
Investments in talent, technology (including AI), and platform enhancements are prioritized to support long-term growth, with the Accelerate 2025 program providing $60 million in savings for reinvestment.
The company remains bullish on the E&S market and delegated authority opportunities, with casualty expected to be a strong growth driver and property anticipated to deliver modest growth in the near term but significant contributions over the long term.